Ansel Hillmer, PhD, and Eric Webb, PhD, have received a $100,000 SNMMI grant for developing a novel PET radiotracer targeting brain inflammation in Alzheimer's disease.
Key Details
- 1Awarded the $100,000 Drs. Jane & Abass Alavi Mars Shot Research Award from SNMMI's 2026 fund.
- 2Research targets colony stimulating factor 1 receptor (CSF1R) as a novel inflammation marker in Alzheimer’s.
- 3Project focuses on developing and validating 18F-PLX5622 as a PET radiotracer.
- 4Initial studies will use mouse models; human tissue validation will follow.
- 5The aim is to enable CSF1R imaging for diagnosis, monitoring, and potential treatment guidance in Alzheimer’s patients.
- 6SNMMI Mars Shot Fund established in 2023 to support visionary nuclear imaging research.
Why It Matters
This research could lead to significant advances in the imaging and understanding of brain inflammation in Alzheimer’s disease, enabling better diagnosis and targeted therapy. It also demonstrates ongoing innovation in PET radiotracer development for neurodegenerative disorders.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.